Electroconvulsive Therapy for a Patient with Suicide by Drinking Bleach During Treatment of COVID-19: A Case Report

Hassani, Valiollah; Amniati, Saied; Kashaninasab, Fatemeh; Niakan, Mohammad; Moghadam, Omid Moradi; Jafarian, Ali; Rad, Reza Farahmand; Sehat-Kashani, Saloome; Habibi, Azadeh

doi:10.5812/aapm.107513

Cited by 11 publications

(6 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In some cases, and in ours as well, intramuscular administration of benzodiazepines and/or haloperidol was used for the rapid management of anxiety and behavioural disturbances [ 28 , 37 , 40 , 45 ]. Electroconvulsive therapy was initiated in cases unresponsive to pharmacological treatment [ 52 , 53 ].…”

Section: Discussion and Brief Review Of Literaturementioning

confidence: 99%

COVID-19-Associated Acute Psychotic Disorder—Longitudinal Case Report and Brief Review of Literature

et al. 2023

View full text Add to dashboard Cite

Even though since the beginning of the COVID-19 pandemic, the literature became more and more abundant on data and hypotheses about the various consequences on people’s lives, more clarity needs to be added to the existing information. Besides the stressful experiences related to the COVID-19 pandemic, SARS-CoV-2 infection has been proven to impact brain functioning through direct and indirect pathogenic mechanisms. In this context, we report a case of a patient presenting with a first episode of psychosis following COVID-19. In our case, a 28-year-old male patient with no personal or family psychiatric history developed psychotic symptoms (delusions, hallucinations, and disorganized behaviour) that required antipsychotic treatment and inpatient hospitalization one week after he was discharged from the hospital after COVID-19. At the six-month and one-year follow-up, the patient was in remission without any psychotic signs or symptoms. A brief review of the literature is also provided. The case presented in this article outlines the possibility that the post-COVD-19 recovery period might be a crucial time for the onset of acute psychotic disorder, and therefore, routine psychiatric assessments should be carried out during all phases of the disease. A clearer picture of the impact of the COVID-19 pandemic on mental health will most likely be revealed in the future as many consequences need long-term evaluation.

show abstract

Section: Discussion and Brief Review Of Literaturementioning

confidence: 99%

COVID-19-Associated Acute Psychotic Disorder—Longitudinal Case Report and Brief Review of Literature

et al. 2023

View full text Add to dashboard Cite

show abstract

“…10,28,29 Successful cases of ECT for urgent patients not at low risk of infection and even for infected patients have been reported. [30][31][32][33][34] For example, ECT in symptomatic patients has been reported in the United Kingdom in a 67-year-old man diagnosed with a major depressive episode with catatonic features. The patient presented with fever and decreased oxygen saturation prior to ECT and was found to be COVID-19 positive.…”

Section: Ect For Patients Not At Low Risk Of Covid-19 Infectionmentioning

confidence: 99%

An Online Survey About Electroconvulsive Therapy in Japan During the COVID-19 Pandemic: Comparison of Early and Recent Stages

Hirata¹,

Kawashima²,

Tsuboi³

et al. 2022

NDT

View full text Add to dashboard Cite

To provide an overview of how electroconvulsive therapy (ECT) practice in Japan has changed as the coronavirus disease 2019 (COVID-19) pandemic continues. Patients and Methods: We surveyed healthcare institutions, primarily university and general hospitals, regarding changes in the number of patients undergoing ECT and infection control measures in the early (August 2020) and recent (August 2021) stages of the COVID-19 pandemic. Data for the early and recent stages were also compared between urban and non-urban areas. Results: Among 32 facilities, the number of patients undergoing ECT decreased in 11 facilities (34.4%) from April 2020 to March 2021 compared with the previous year, whereas the number increased in 12 (37.5%) from April to June 2021 compared with the previous year. As of August 2021, some facilities had ongoing restrictions. Compared with non-urban facilities, the number of patients undergoing ECT decreased more in urban facilities, which also had more ECT restrictions. Maintenance ECT was used at the same rate as before the pandemic for 23 (82.1%) of 28 institutions. Regarding infection control measures, many facilities considered polymerase chain reaction testing before ECT and required all staff to wear surgical masks and eye shields during ECT. Conclusion:The COVID-19 pandemic in Japan greatly affected the use of ECT in 2020; however, by the summer of 2021, infection control measures were relatively well established, the number of ECT cases stabilized and increased, and the decision to use ECT was again possible.

show abstract

“…Clearly, providing strategies to prevent ECT cancelations is as important as surgical cases. Indeed, ECT is the last life-saving option in resistance cases and those at risk of suicide (4)(5)(6). Therefore, regular and uninterrupted treatment sessions are crucial for these cases.…”

Section: Introductionmentioning

confidence: 99%

Evaluation of the Efficacy of the ECT Patients Preparation Checklist in Reducing the Cancellation Rate in an Academic Hospital

et al. 2022

View full text Add to dashboard Cite

Background: Electroconvulsive therapy (ECT) is a vital treatment strategy for psychiatric patients, and cancellation of the procedure negatively impacts the recovery process. However, it may happen due to the lack of optimal conditions at admission. Methods: This retrospective study occurred at Shafa Hospital, an academic center affiliated with the Guilan University of Medical Sciences (GUMS). The ECT anesthesia team developed an ECT patient preparation checklist, which was shared with psychiatrists. The rate and some related factors of case cancellation were compared between the two years before presenting the checklist, from May 2019 to May 2020, and the next year, from June 2020 to May 2021. The patients’ files were reviewed, and the required information was documented. Results: One hundred fifty-one cancellations were recorded during the two years of study, 82 cases in the first year and 69 in the second year. The most common reason for the cancellation was inadequate consultations followed by abnormal lab tests. In comparing the number of cancellations between the two years, before and after the checklist was provided, no significant difference was observed in terms of age (P = 0.288), gender (P = 0.24), psychiatric disorder (P = 0.399), and the number of ECT sessions (P = 0.36). However, the number of cancellations due to incomplete consultation significantly decreased after developing the checklist (P = 0.049), while unstable hemodynamics and changing patients’ conditions on an intended day also increased (P = 0.024). Residency visits did not significantly affect the number of cancellations over 2 years (P = 0.139). Conclusions: This study concluded that preparing ECT patients according to the checklist led to better conditions and fewer cancellations. However, preventable causes still exist.

show abstract

Electroconvulsive Therapy for a Patient with Suicide by Drinking Bleach During Treatment of COVID-19: A Case Report

Cited by 11 publications

References 18 publications

COVID-19-Associated Acute Psychotic Disorder—Longitudinal Case Report and Brief Review of Literature

COVID-19-Associated Acute Psychotic Disorder—Longitudinal Case Report and Brief Review of Literature

An Online Survey About Electroconvulsive Therapy in Japan During the COVID-19 Pandemic: Comparison of Early and Recent Stages

Evaluation of the Efficacy of the ECT Patients Preparation Checklist in Reducing the Cancellation Rate in an Academic Hospital

Contact Info

Product

Resources

About